Analog Devices Inc: Form 10-Q for the period ended Apr 29, 2023
Filed with the SEC on May 24, 2023 and accepted by EDGAR at May 24, 2023, 07:03 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-04-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-29 to 2023-04-29 | $3.26bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2022-10-30 to 2023-04-29 | $6.51bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-29 to 2023-04-29 | $1.12bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2022-10-30 to 2023-04-29 | $2.24bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-01-29 to 2023-04-29 | $2.14bn | us-gaap:GrossProfit |
| Gross profit | 6 months2022-10-30 to 2023-04-29 | $4.27bn | us-gaap:GrossProfit |
| Research and development | 3 months2023-01-29 to 2023-04-29 | $415.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-10-30 to 2023-04-29 | $829.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-01-29 to 2023-04-29 | $324.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-10-30 to 2023-04-29 | $650.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-29 to 2023-04-29 | $1.13bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-10-30 to 2023-04-29 | $2.26bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-29 to 2023-04-29 | $63.3m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-10-30 to 2023-04-29 | $123.7m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-29 to 2023-04-29 | $110.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-10-30 to 2023-04-29 | $222.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-29 to 2023-04-29 | $977.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-10-30 to 2023-04-29 | $1.94bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-29 to 2023-04-29 | $1.92 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-10-30 to 2023-04-29 | $3.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-29 to 2023-04-29 | $1.94 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-10-30 to 2023-04-29 | $3.83 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-29 to 2023-04-29 | 508,725,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-10-30 to 2023-04-29 | 509,955,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-10-30 to 2023-04-29 | $2.49bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-10-30 to 2023-04-29 | $460.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2022-10-30 to 2023-04-29 | $820.7m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2022-10-30 to 2023-04-29 | $1.81bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-04-29 | $1.18bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-04-29 | $4.74bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-04-29 | $49.54bn | us-gaap:Assets |
| Current liabilities | At period end2023-04-29 | $2.65bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2023-04-29 | $6.52bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2023-04-29 | $253.6m | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2023-04-29 | $36.01bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-04-29 | 501,418,304 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000006281-23-000152. Last ingested by Listed: Oct 27, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.